Company Overview and News
Stop missing out on important events!
Hong Kong's benchmark index Hang Seng ended Friday at a record high, capping its seventh week of gains, amid optimism towards global economic recovery and accelerated money inflows from mainland China. At close of trade, the Hang Seng index was up 499.67 points or 1.53 per cent at 33,154.12. The Hang Seng China Enterprises index rose 2.51 per cent to 13,723.96. (1-0)
Hong Kong stocks rose to the highest level in over a decade on Tuesday, aided by a surge in property shares as well as China's H-Share full convertibility reform which is generally viewed as positive to Hong Kong-listed Chinese companies. China stocks also started 2018 trading on a bullish note on better-than-expected December manufacturing activity. (2-0)
Fosun Pharma (SHA: 600196; HK: 2196) obtained China rights to tenapanor, an Ardelyx (NASDAQ:ARDX) treatment for irritable bowel syndrome with constipation (IBS-C), in a $125 million agreement. Tenapanor is also expected to treat hyperphosphatemia related to chronic kidney disease. Ardelyx, a San Francisco area company, has completed US Phase III trials in which tenapanor met efficacy endpoints in both indications. (23-0)
Global pharmacy and health care company Walgreens Boots Alliance said on Wednesday it had signed an agreement with Sinopharm Group, China’s largest retailer of pharmaceutical and health care products, in a deal worth 2.76 billion yuan (US$417 million). (2-0)
Hong Kong's benchmark Hang Seng Index broke through the 30,000 point-mark on Wednesday for the first time in 10 years, amid signs Chinese investors are stepping up buying Hong Kong blue chips such as Tencent. China stocks also rose.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (276-0)
Investors piled into financial stocks, betting Beijing’s move to widen foreign access to its giant financial sector would attract fresh foreign capital inflows, and push up the valuations of Chinese lenders, insurers and brokerages. — Reuters picSHANGHAI, Nov 13 — China stocks rose today morning, led by banks, as excitement over financial deregulation unveiled last week continued to boost sentiment, mitigating wider concerns about higher corporate borrowing costs amid rising bond yields.
HONG KONG, CHINA--(Marketwired - Aug 16, 2017) - The global law firm Jones Day has announced that Charles Chau has joined the Firm's Hong Kong Office as a partner in its M&A Practice.
HONG KONG (Reuters) - U.S. drug distributor Cardinal Health has put its China business up for sale, drawing keen interest from state-backed Chinese pharmaceutical firms in a deal that may be worth up to $1.5 billion, sources familiar with the matter said.
As many as 19 Chinese state companies listed on the Hong Kong Stock Exchange have established Communist Party committees. Whose rules do they hew to?
oncgnostics grants exclusive license for GynTect to the Chinese SINOPHARM subsidiary CJMT; Approval for the Chinese market planned
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
A group of Chinese pharmacy chains has demanded the abolition of a medicine tracking platform run by Alibaba Health Information Technology, piling further pressure on the firm after China's drug regulator suspended the system on Saturday.
SHANGHAI A group of Chinese pharmacy chains has demanded the abolition of a medicine tracking platform run by Alibaba Health Information Technology, piling further pressure on the firm after China's drug regulator suspended the system on Saturday.